Written by Klarity Editorial Team
Published: May 13, 2026

If you’re a psychiatrist or PMHNP wondering whether you can legally prescribe antidepressants and other medications via telehealth in 2026, the short answer is: yes, absolutely — and the regulatory landscape is more provider-friendly than ever.
But the full answer depends on what you’re prescribing, where your patient is located, and whether you’re an MD/DO or a nurse practitioner. Let’s cut through the confusion.
Here’s the big news: the DEA and HHS just announced a fourth temporary extension of COVID-era telehealth rules, allowing providers to prescribe controlled substances via telemedicine through December 31, 2026 — without requiring an initial in-person exam.
This means you can continue initiating treatment for depression patients who also need medications like:
All via a live video consultation. No mandated in-person visit first.
The catch? This is still a temporary rule. The DEA is working on permanent regulations (proposed January 2025) that would create a special telemedicine registration for prescribers. Under the draft rules, psychiatrists would be among the specialists explicitly allowed to tele-prescribe Schedule II controlled substances without an in-person exam — but you’d need to obtain this new registration.
For now, though, you’re operating under the extended COVID flexibilities. That buys you until the end of 2026 to prepare for whatever the final rules look like.
Before COVID, the Ryan Haight Online Pharmacy Consumer Protection Act required practitioners to conduct at least one in-person medical evaluation before prescribing any controlled substance via telemedicine. This was the law of the land from 2008 until the pandemic.
The Public Health Emergency effectively suspended that requirement in 2020, and the DEA has extended the suspension repeatedly — most recently through December 31, 2026.
What this means for depression treatment:
The upcoming permanent DEA rules (still in public comment as of early 2026) propose allowing board-certified psychiatrists to obtain an ‘Advanced Telemedicine Prescribing’ registration specifically for Schedule II drugs. If enacted as proposed, this would formalize what you’re already doing and make it permanent — but with potential new reporting or registration requirements.
Bottom line: you’re good through 2026, and the DEA is moving toward making telepsychiatry prescribing a permanent feature for specialists like you, not rolling it back.
Your scope of practice and regulatory burden depends heavily on your credential and the state you’re practicing in.
You have the broadest authority. In every state:
The only restrictions you face are:
Your authority varies widely by state. The big question is whether your state has full practice authority (FPA) for NPs.
Full practice states (as of 2026):
In these states, you can join a platform like Klarity Health and see patients without a supervising physician. You’ll need your own DEA registration and state license, but you operate as an autonomous provider.
Restricted practice states (as of 2026):
In these states, you can still practice telepsychiatry and manage depression patients — you just need a collaborating physician on file. For platforms like Klarity, this may mean pairing you with a psychiatrist supervisor depending on the state.
Controlled substance prescribing for NPs:Even in full-practice states, some have nuances:
For treating depression, this mostly affects your ability to prescribe stimulants (Adderall, Ritalin) for treatment-resistant cases or comorbid ADHD. In full-practice states, you’re clear. In restricted states, your supervising physician may need to be involved in those prescriptions.
Federal DEA rules set the floor, but states can impose additional requirements. Here’s what matters for the six priority states where Klarity operates:
Takeaway: California is telehealth-friendly and has strong parity laws. If you’re licensed in CA (or willing to get licensed), you can build a full telepsychiatry practice here with minimal red tape.
Takeaway: Texas reformed its telemedicine laws in 2017 (removing the prior in-person requirement), but still maintains tighter rules on certain practices. For depression treatment, you’re clear — just make sure to use video for new patient evals and avoid managing chronic pain conditions via tele.
Telehealth prescribing: Florida allows out-of-state providers to register for telehealth (Florida Statute 456.47) without obtaining a full FL license. However, you must renew this registration every two years.
Controlled substances: Here’s the key rule — Schedule II controlled substances cannot be prescribed via telehealth in Florida, except for:
Psychiatric disorders
Inpatient hospital care
Hospice patients
Nursing home residents
Since depression is a psychiatric disorder, you can prescribe Adderall, Ritalin, or other Schedule IIs via telehealth for depression or comorbid ADHD. You just need to document that it’s for a psychiatric indication.
NP scope: Psychiatric NPs are not eligible for autonomous practice in Florida. You need a supervising psychiatrist and a protocol agreement.
Licensure: Either a full FL license or an out-of-state telehealth registration. FL is an IMLC member for physicians.
Takeaway: Florida is relatively friendly for telepsychiatry. The Schedule II carve-out for psychiatric treatment is explicit in the law, so you’re covered for most depression-related prescribing. Just ensure you check Florida’s PDMP (E-FORCSE) before prescribing controlled substances.
Takeaway: New York is progressive for both telehealth and NP independence. If you’re a PMHNP with 3,600+ hours, you can run a fully autonomous telepsychiatry practice in NY. Psychiatrists face minimal barriers beyond licensure.
Takeaway: PA is moderately telehealth-friendly but lacks comprehensive legislation, which creates some regulatory uncertainty. For depression treatment, you’re clear to practice via video — just document thoroughly and maintain the required NP collaborative agreement if applicable.
Takeaway: Illinois is highly favorable for telehealth psychiatric practice. If you’re a PMHNP with Full Practice Authority, you can fully manage depression patients independently. The state has clear rules and strong support for expanding mental health services via telemedicine.
| State | NP Independence? | Telehealth Prescribing Rules | Controlled Substance Restrictions | Licensure Notes |
|---|---|---|---|---|
| California | Yes (experienced PMHNPs, 2024+) | No in-person exam required; standard of care applies | None beyond federal law | Full CA license required; not in IMLC |
| Texas | No (collaborative agreement required) | Video required for new patients; phone-only insufficient | Chronic pain management prohibited via tele | Full TX license; IMLC member |
| Florida | No (psych NPs excluded from autonomy) | Out-of-state telehealth registration available | Schedule II allowed for psychiatric disorders only | Full license or telehealth registration; IMLC member |
| New York | Yes (3,600+ hours experience) | No restrictions; audio-only allowed for behavioral health | None beyond federal law | Full NY license required; not in IMLC |
| Pennsylvania | No (collaborative agreement required) | No formal statute; standard of care applies | None beyond federal law | Full PA license; IMLC member |
| Illinois | Yes (FPA after 4,000 hours) | Insurance parity; no in-person requirement | FPA-NPs need consultation process for chronic Schedule II opioids | Full IL license; IMLC member |
Here’s the reality most providers don’t talk about: acquiring psychiatric patients through traditional marketing is expensive and unpredictable.
If you try to build your own practice through:
Total cost to acquire a qualified psychiatric patient through DIY marketing? $200–500+ when you factor in all the hidden costs — agency fees, ad spend testing, staff time, no-show rates from cold leads, and months of waiting.
The alternative: Platforms like Klarity Health use a pay-per-appointment model. You pay a standard listing fee per new patient lead, but only when they book with you. No upfront marketing spend. No monthly subscription gambling. No wasted ad budget on clicks that don’t convert.
The value proposition:
Instead of spending $3,000–5,000/month on marketing with uncertain results, you pay only when a qualified patient books with you. That’s guaranteed ROI vs. gambling on marketing channels you may not have the expertise to optimize.
Can DIY marketing eventually be cost-effective? Sure — if you have the budget, expertise, and patience. But for most providers, especially those starting out or scaling, a platform that handles patient acquisition removes the risk entirely.
Can I prescribe antidepressants via telehealth without ever seeing a patient in person?
Yes. Non-controlled antidepressants (SSRIs, SNRIs, bupropion, mirtazapine, etc.) can be prescribed via telehealth under the same standard of care as in-person. Federal law doesn’t require an in-person exam, and most states follow suit.
What about benzodiazepines or stimulants for depression patients?
Under the current DEA extension (through December 31, 2026), you can prescribe these via telehealth after a live video consultation without an initial in-person exam. When the permanent rules are finalized (expected late 2026), psychiatrists will likely need to obtain a special telemedicine registration but will still be able to prescribe Schedule II drugs for psychiatric conditions.
Do I need a separate license in every state where I see patients?
Yes. Telehealth doesn’t change licensure requirements. You must be licensed (or hold a valid telehealth registration, where available) in the state where the patient is located at the time of the consult.
Can PMHNPs prescribe controlled substances independently?
It depends on the state. In full-practice states (NY, CA, IL), experienced PMHNPs can prescribe controlled substances independently after obtaining the required experience hours and registrations. In restricted states (TX, FL, PA), you need a collaborative agreement with a physician.
What’s the difference between the Interstate Medical Licensure Compact and regular licensure?
The IMLC is a voluntary compact that streamlines the process for physicians to obtain licenses in multiple states. If you hold a full, unrestricted license in an IMLC member state, you can use the IMLC to apply for licenses in other member states more quickly. Texas, Florida, Pennsylvania, and Illinois are IMLC members. California and New York are not.
Do I need to check a prescription monitoring program before prescribing?
Yes, in most states. When prescribing controlled substances, you’re required to check the state’s PDMP (prescription drug monitoring program) to review the patient’s controlled substance history. This applies whether you’re practicing in-person or via telehealth.
Can I use audio-only (phone) for telehealth visits?
For new patients, most states require live video to establish a patient relationship and prescribe. Some states (like New York and Illinois) have allowed audio-only for behavioral health services, particularly during COVID extensions, but best practice is to use video when possible. Audio-only is generally acceptable for established patients in follow-up visits.
What happens if the DEA extension expires in 2027 without new permanent rules?
If the DEA doesn’t finalize permanent telemedicine rules by December 31, 2026, providers would theoretically revert to the Ryan Haight Act’s in-person exam requirement for controlled substances. However, given the political and clinical pressure to maintain access to telepsychiatry, it’s highly unlikely the DEA would let the extension lapse without a replacement framework in place.
The regulatory landscape for prescribing depression medications via telehealth is more favorable than it’s ever been — and it’s moving toward permanent expansion, not restriction.
If you’re a psychiatrist or PMHNP looking to:
Platforms like Klarity Health remove the patient acquisition risk entirely. You focus on clinical care. We handle the rest.
Explore joining Klarity’s provider network and see how our pay-per-appointment model compares to the $200–500+ you’d spend acquiring each patient on your own.
U.S. Department of Health & Human Services. (January 2, 2026). HHS & DEA Extend Telemedicine Flexibilities for Prescribing Controlled Medications Through 2026. https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html
U.S. Drug Enforcement Administration. (January 16, 2025). DEA Announces Three New Telemedicine Rules to Continue Open Access to Care. https://www.dea.gov/press-releases/2025/01/16/dea-announces-three-new-telemedicine-rules-continue-open-access
Florida Legislature. Florida Statutes §456.47 – Use of Telehealth to Provide Services. https://www.leg.state.fl.us/statutes/index.cfm?Appmode=DisplayStatute&URL=0400-0499/0456/Sections/0456.47.html
California Board of Registered Nursing. AB 890 Implementation – Nurse Practitioner Practice Authority. https://www.rn.ca.gov/practice/ab890.shtml
Rivkin Radler LLP. (April 13, 2022). New Law Allows Experienced NPs to Practice Independently in NY. https://www.rivkinrounds.com/2022/04/new-law-allows-experienced-nps-to-practice-independently-in-ny/
Find the right provider for your needs — select your state to find expert care near you.